JP2003012552A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003012552A5 JP2003012552A5 JP2002122734A JP2002122734A JP2003012552A5 JP 2003012552 A5 JP2003012552 A5 JP 2003012552A5 JP 2002122734 A JP2002122734 A JP 2002122734A JP 2002122734 A JP2002122734 A JP 2002122734A JP 2003012552 A5 JP2003012552 A5 JP 2003012552A5
- Authority
- JP
- Japan
- Prior art keywords
- pro
- agent according
- formula
- gnrh agonist
- sustained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003795 chemical substances by application Substances 0.000 claims 9
- NMJREATYWWNIKX-UHFFFAOYSA-N GnRH Chemical compound C1CCC(C(=O)NCC(N)=O)N1C(=O)C(CC(C)C)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)CNC(=O)C(NC(=O)C(CO)NC(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C(CC=1NC=NC=1)NC(=O)C1NC(=O)CC1)CC1=CC=C(O)C=C1 NMJREATYWWNIKX-UHFFFAOYSA-N 0.000 claims 6
- 101000857870 Squalus acanthias Gonadoliberin Proteins 0.000 claims 6
- 239000000556 agonist Substances 0.000 claims 6
- 108090000765 processed proteins & peptides Proteins 0.000 claims 4
- 239000005557 antagonist Substances 0.000 claims 3
- 239000003094 microcapsule Substances 0.000 claims 3
- 238000013268 sustained release Methods 0.000 claims 3
- 239000012730 sustained-release form Substances 0.000 claims 3
- 229920002988 biodegradable polymer Polymers 0.000 claims 2
- 239000004621 biodegradable polymer Substances 0.000 claims 2
- 239000003405 delayed action preparation Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- XBBVURRQGJPTHH-UHFFFAOYSA-N 2-hydroxyacetic acid;2-hydroxypropanoic acid Chemical group OCC(O)=O.CC(O)C(O)=O XBBVURRQGJPTHH-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 206010057654 Breast cancer female Diseases 0.000 claims 1
- 125000000030 D-alanine group Chemical group [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 claims 1
- 125000002437 D-histidyl group Chemical group N[C@@H](C(=O)*)CC=1N=CNC1 0.000 claims 1
- 125000003301 D-leucyl group Chemical group N[C@@H](C(=O)*)CC(C)C 0.000 claims 1
- 125000000734 D-serino group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 230000007774 longterm Effects 0.000 claims 1
- 229920000747 poly(lactic acid) Polymers 0.000 claims 1
- 239000004626 polylactic acid Substances 0.000 claims 1
- 229920000642 polymer Polymers 0.000 claims 1
- 230000002980 postoperative effect Effects 0.000 claims 1
- 230000003449 preventive effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002122734A JP2003012552A (ja) | 2001-04-25 | 2002-04-24 | 閉経前乳癌の術後再発予防剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001-128032 | 2001-04-25 | ||
| JP2001128032 | 2001-04-25 | ||
| JP2002122734A JP2003012552A (ja) | 2001-04-25 | 2002-04-24 | 閉経前乳癌の術後再発予防剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003012552A JP2003012552A (ja) | 2003-01-15 |
| JP2003012552A5 true JP2003012552A5 (https=) | 2005-09-02 |
Family
ID=26614210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002122734A Pending JP2003012552A (ja) | 2001-04-25 | 2002-04-24 | 閉経前乳癌の術後再発予防剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003012552A (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020505379A (ja) * | 2017-01-20 | 2020-02-20 | イミューン システム レギュレェイション ホールディング エービー | 新規化合物（イムノレリン） |
| JP2020505378A (ja) | 2017-01-20 | 2020-02-20 | イミューン システム レギュレェイション ホールディング エービー | 新規化合物（イムノヘリン−細胞内感染） |
| US11672842B2 (en) | 2017-02-22 | 2023-06-13 | ISR Immune System Regulation Holding AB (publ) | Gonadotropin-releasing hormones for use as adjuvant immunotherapeutics |
-
2002
- 2002-04-24 JP JP2002122734A patent/JP2003012552A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2247735T3 (es) | Peptidos opiaceos afines a receptores kappa. | |
| AU2024201411A1 (en) | 1,2,4-oxadiazole compounds as inhibitors of CD47 signalling pathways | |
| ES2203823T3 (es) | Analogos heptapeptidicos de oxitocina. | |
| RU2496788C2 (ru) | Аналоги окситоцина | |
| JP2003206240A5 (https=) | ||
| DK0973801T3 (da) | GnRH-antagonister | |
| BR0317600A (pt) | ácidos heteroarilalcanóicos como derivados de antagonistas de receptor de integrina | |
| RU2000121545A (ru) | Композиции длительного высвобождения, способ их получения и применение | |
| CA2451718A1 (en) | Sustained-release composition comprising lactic acid-glycolic acid copolymer and process for producing the same | |
| IE903881A1 (en) | GnRH ANALOGS | |
| IE903671A1 (en) | Therapeutic decapeptides | |
| RU2004102507A (ru) | Композиция с регулируемым высвобождением и способ ее получения | |
| ES2230581T3 (es) | Utilizacion de antagonistas no peptidicos de la bradiquinina en la preparacion de medicamentos para el tratamiento y prevencion de la enfermedad de alzheimer. | |
| RU2227145C2 (ru) | Антагонисты lhrh и способ их получения, фармацевтическая композиция, способ получения лекарственного средства | |
| WO2001096307A3 (en) | Cycloalkyl alkanoic acids as integrin receptor antagonists | |
| JP2003012552A5 (https=) | ||
| RU2020104475A (ru) | КОНЪЮГИРОВАННОЕ С ПАЛЬМИТИНОВОЙ КИСЛОТОЙ ПРОИЗВОДНОЕ GnRH ПРОЛОНГИРОВАННОГО ДЕЙСТВИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЕГО | |
| US20080207524A1 (en) | Medicinal preparations for treating sex hormone-dependent diseases | |
| DE60006542D1 (de) | Verbindungen die die tryptase-activität hemmen | |
| IE920825A1 (en) | GnRH Analogs | |
| US5698522A (en) | 6-position modified decapeptide LHRH antagonists | |
| JP2003206243A5 (https=) | ||
| EP0738154A1 (en) | N-terminus modified analogs of lhrh | |
| HU181402B (en) | Process for preparing new peptides with psychopharmacological activity | |
| JP2004526702A5 (https=) |